Outlook Therapeutics Inc
(NASDAQ:OTLK)
$1.165
0.015[1.30%]
Last update: 12:59PM (Delayed 15-Minutes)
Get Real Time Here
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary

Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.

Loading...
Day Range1.140 - 1.19052 Wk Range0.684 - 2.120Open / Close1.190 / -Float / Outstanding180.713M / 256.667M
Vol / Avg.77.384K / 497.016KMkt Cap299.017MP/E-50d Avg. Price1.050
Div / Yield (Forward)- / -%Payout Ratio-Total Float180.713MEPS-0.310
Seeking Alpha - Dec 29, 2022, 9:45AM
Seeking Alpha - Dec 23, 2022, 6:29AM
InvestorsObserver - Oct 7, 2022, 12:34PM
Sector: Health Care.Industry: Biotechnology
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-02-13
REV
Q4 2022Est.ActualSurprise
EPS-0.070-0.060 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Outlook Therapeutics (OTLK) stock?

A

You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Outlook Therapeutics's (OTLK) competitors?

Q

What is the target price for Outlook Therapeutics (OTLK) stock?

A

The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Outlook Therapeutics (OTLK)?

A

The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.

Q

Does Outlook Therapeutics (OTLK) pay a dividend?

A

There are no upcoming dividends for Outlook Therapeutics.

Q

When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?

A

Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.

Q

Is Outlook Therapeutics (OTLK) going to split?

A

There is no upcoming split for Outlook Therapeutics.

Q

What sector and industry does Outlook Therapeutics (OTLK) operate in?

A

Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.